Pharmaceuticals

Our aim is to publish updated reviews as well as research articles with comprehensive theoretical and experimental details. Short communications are also accepted; therefore, there is no restriction on the length of a paper. The multidiciplinary journal welcomes manuscripts covering a wide range of aspects involved in drug discovery and development. The following topics are considered: Small molecules as drug candidates: drug discovery, drug design, medicinal chemistry, combinatorial chemistry, SAR, structure-property correlations, molecular modeling, pharmacophore, and bioinformatics; Biomolecules, natural products, phages, and cells as therapeutic tools: peptides, aptamers, glycans, antibodies, extracts, bacteriophages, and stem cells; Biological targets and biomarkers: enzymes, receptors, membranes, genes, ion channels, inhibitors, agonists, antagonists, neurons, binding affinity, biofilms, bacteria, viruses, parasites, and protein–protein interactions; Radiopharmaceutical sciences, radiochemistry, (hybrid-)imaging, and nuclear medicine: radiopharmaceuticals, radiotracers, fluorescent dye labeled tracers, contrast agents, PET/CT, PET/MRI RMI, SPECT/CT, and scintigraphy; Pharmacokinetics and pharmacodynamics: pharmaceutical analyses, drug effects, ADME, animal experimentation, and clinical trials; Pharmaceutical preparations and drug delivery: dosage form design, bioconjugates, prodrugs, formulation, metabolites, nanomaterials, nanomedicines, and drug targeting.